CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,040,000 | +108.5% | 78,197 | 0.0% | 0.16% | +117.1% |
| Q2 2022 | $1,938,000 | -1.1% | 78,197 | 0.0% | 0.08% | +10.1% |
| Q1 2022 | $1,960,000 | -31.2% | 78,197 | 0.0% | 0.07% | -25.0% |
| Q4 2021 | $2,847,000 | +112.9% | 78,197 | 0.0% | 0.09% | +114.0% |
| Q3 2021 | $1,337,000 | +27.7% | 78,197 | 0.0% | 0.04% | +26.5% |
| Q2 2021 | $1,047,000 | -85.9% | 78,197 | -45.9% | 0.03% | -86.7% |
| Q1 2021 | $7,401,000 | -17.3% | 144,447 | 0.0% | 0.26% | -18.8% |
| Q4 2020 | $8,944,000 | +13.0% | 144,447 | 0.0% | 0.31% | +5.7% |
| Q3 2020 | $7,916,000 | – | 144,447 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |